Literature DB >> 22414979

Pregnancy after successful cancer treatment: what needs to be considered?

Barbara Lawrenz1, Melanie Henes, Eva Neunhoeffer, Tanja Fehm, Stephanie Huebner, Lothar Kanz, Patricia Marini, Frank Mayer.   

Abstract

Over the last decade, advances in oncology led to improved treatment results and increasing numbers of long-term cancer survivors. Fulfilling the desire to have children is important for many patients after cancer treatment. Consequently, oncologists, gynecologists and obstetricians are seeing more patients who wish to conceive after treatment. The necessary prerequisites that should be considered when supporting a planned pregnancy after cancer treatment are discussed in this article. The possible consequences of chemotherapy and radiotherapy on the course of pregnancy and the health of the offspring, as well as the interactions between cancer and pregnancy, are reviewed with the focus on childhood cancer, malignant lymphomas, and breast cancer. Despite chemo- or radiotherapy, neither the teratogenic risk nor the risk of adventitious cancers appears to be increased for the offspring of cancer survivors. However, there is a slightly higher risk of miscarriage after chemotherapy. In case of radiation to the uterus, there is a higher risk of premature birth, intrauterine growth retardation, and increased perinatal mortality. The effect is more pronounced after prepubertal radiation than for postpubertal radiation. The former cancer patient's desire to conceive can nevertheless be supported, given that pregnancy and birth are closely monitored.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22414979     DOI: 10.1159/000336830

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  5 in total

1.  Vaginal delivery after hemipelvectomy and pelvic radiotherapy for chondrosarcoma.

Authors:  J L Browne; M A Oudijk; H R Holtslag; H W R Schreuder
Journal:  BMJ Case Rep       Date:  2014-09-25

2.  Fertility counseling of young breast cancer patients.

Authors:  Matteo Lambertini; Paola Anserini; Alessia Levaggi; Francesca Poggio; Lucia Del Mastro
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

3.  Cancer and fertility preservation: international recommendations from an expert meeting.

Authors:  Matteo Lambertini; Lucia Del Mastro; Maria C Pescio; Claus Y Andersen; Hatem A Azim; Fedro A Peccatori; Mauro Costa; Alberto Revelli; Francesca Salvagno; Alessandra Gennari; Filippo M Ubaldi; Giovanni B La Sala; Cristofaro De Stefano; W Hamish Wallace; Ann H Partridge; Paola Anserini
Journal:  BMC Med       Date:  2016-01-04       Impact factor: 8.775

Review 4.  Obstetric and offspring risks of women's morbid conditions linked to prior anticancer treatments.

Authors:  Juan J Tarín; Miguel A García-Pérez; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2016-07-07       Impact factor: 5.211

Review 5.  Cancer treatment in pregnant women.

Authors:  Pawel Basta; Anna Bak; Krzysztof Roszkowski
Journal:  Contemp Oncol (Pozn)       Date:  2014-10-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.